2014 Final Program - SCABB

2014

Presented by:

Final Program

March 29 & 30 - Fort Worth, Texas

www.scabb.org

2014 Advanced Immunohematology

& Molecular Symposium

Welcome to AIMS

2

I am delighted to welcome you to the 2014 Advanced Immumohematology and Molecular

Symposium in the Texas town of Fort Worth. The program committee for this phenomenal

meeting has again produced an outstanding program for your professional development.

The symposium starts with the very popular “Ask the Experts” and concludes with

“Remembering the History” with many power sessions in between, including W. John Judd,

the John Moulds Memorial Lecturer.

I hope you also take some time to enjoy the area with its numerous restaurants, museums,

shopping venues and nightlife all within walking distance. The historic hotel, formerly The

Hotel Texas, is where President and Mrs. John F. Kennedy stayed on their last night

together on November 21, 1963. The next morning President Kennedy spoke just hours

before his assassination in Dallas by saying, “There are no faint hearts in Fort Worth.” It

is an honor to host AIMS in this historic city, where you can gather to learn, network and

yes, have a good ‘ol time!

I am an RN by training, and don’t always understand the complexity of your work, but I

have a great deal of respect and admiration for each of you in the very

important role you play in the life-saving mission of transfusion medicine. I look forward

to seeing you and hope you leave the meeting inspired.

Jeannie Gardner, RN

Oklahoma Blood Institute

56th SCABB President

Welcome to Fort Worth and the 5th meeting of the Advanced Immunohematology & Molec-

ular Symposium (AIMS). This year I am excited to have John Judd as the John Moulds

Memorial Lecturer. He will be joined by several other leaders in the immunohematology

industry to provide another exciting year of top notch educational sessions. Along with the

education, our group “AIMs” to offer opportunities for peer interaction and face time with

vendors. Oh, yeah, and a bit of fun as well! If you are a returning participant, it’s great to

see you again. If this is your first time, I hope the meeting exceeds your expectations.

Once again – Welcome!

Katrina Billingsley, MT(ASCP)SBB

LifeShare Blood Centers

AIMS Committee Chair

3

(866) 649-9550

March 29 & 30

Fort Worth, Texas

3

SATURDAY, MARCH 29

TIME TRACK/ROOM PRESENTATION/EVENT SPEAKERS

7:00 - 5:00 West Promenade Registration Open

8:00 - 9:00 Texas CD Ask the Experts Panel of Experts

9:00 - 10:00 Texas CD Hiding in Plain Sight Mark D. Scott, PhD

10:00 - 10:15 BREAK

10:15 - 11:45 Texas CD Star Wars, the Empire Strikes Back Joann Moulds, PhD, MT(ASCP)SBB Sue Johnson, MSTM, MT(ASCP)SBB

12:00 - 1:00 Continental AIMS Industry Workshop

presented by Grifols LUNCH PROVIDED BY GRIFOLS

Mark Yazer, MD

1:15 - 2:45 Texas CD Are We Doing it Right? Margaret A. Keller, PhD

Mary A Lieb MT(ASCP)SBB, CQA(ASQ)

2:45 - 3:00 BREAK

3:00 - 5:00 Texas CD Case Studies

Brian Jones, SBB(ASCP)CM Sandy Wortman, MT(ASCP)SBB

Virginia Reyes, M.Ed., MT(ASCP)SBBCM David Hanna, MT(ASCP)CM

SUNDAY, MARCH 30

TIME TRACK/ROOM PRESENTATION/EVENT SPEAKERS

8:30 - 10:00 Texas CD Let's Talk About Platelets Stan Hance MT(ASCP)

Katrina Billingsley, MT(ASCP) SBB Frank Nizzi, DO

10:00 - 10:15 BREAK

10:15 - 12:00 Texas CD Remembering the History

(John Moulds Memorial Lecturer) Tony Casina MT(ASCP)SBB

W. John Judd, FIBMS, MIBiol

12:00 - 5:00 West Promenade Annual Meeting Registration Open

2:15 - 3:15 Continental AM Industry Workshop

Presented by Healthcare-ID Bart Block

3:30 - 6:30 Crystal Ball Room A

Opening Plenary Technical/Scientific Award Lecturer

Administrative Award Lecturer Karen Williams Memorial Lecturer

Merlyn Sayers, MBBCh, PhD Scott Jones, PhD

Joann Moulds, PhD, MT (ASCP)SBB Evan Bloch, MD

Schedule At A Glance

www.scabb.org



John Moulds Memorial Lecturer

4

W. John Judd, FIBMS, MIBiol

Emeritus Professor, University of Michigan

Professor W. John Judd is an Emeritus

Professor of Immunohematology in the

Department of Pathology at the University of

Michigan. He served on the AABB Board of

Directors and numerous AABB committees.

Professor Judd is the Past President of the

Michigan Association of Blood Banks and is

the author of over 100 publications, including

Judd's Methods in Immunohematology, ed 3.

Endowed by: LifeShare Blood Centers & Quotient Biodiagnostics

This Symposium is one of the many

educational modules presented by SCABB.

——— NOT A MEMBER? ———

Consider joining today @ www.scabb.org

5

(866) 649-9550

March 29 & 30

Fort Worth, Texas

AIMS Sponsor Directory

5

Immucor, Inc.

3130 Gateway Drive

Norcross, GA 30071

770-441-2051

www.immucor.com

Grifols

4560 Horton Street

Emeryville, CA 94608

510-499-2756

www.grifols.com

Quotient Biodiagnostics

301 S. State Street, Suite S-204

Newton, PA 18940

214-533-3085

www.quotientbd.com

Katrina Billingsley - Chair Joann Moulds

Sandy Wortman - Co-chair Suzanne Davisson

Virginia Reyes Lauro Guerra

Margaret Keller Brian Jones

2013 - 2014 AIMS Committee

www.scabb.org



6

Detailed Schedule

Saturday, March 29

*All AIMS sessions are located in Texas CD*

Ask the Experts

8:00 - 9:00 AM

Moderator: Katrina Billingsley, MT(ASCP) SBB

Speaker(s): Joann Moulds, PhD, MT(ASCP)SBB

Margaret A. Keller, PhD

Frank Nizzi, DO

Mary A. Lieb, MT(ASCP)SBB, CQA(ASQ)

Sue Johnson, MSTM, MT(ASCP)SBB

Presentation: Ask the Experts

Description: Join us as our panel of experts discuss best practices in the areas of

immunohematology, genotyping, quality assurance and clinical practice. Questions

can be submitted in advance or during the session.

Objectives:

1. Review options for complex serological work-ups

2. Discuss applications of red cell genotyping

3. Evaluate quality assurance practices

PACE/CME Credits: 1 PACE/CME

151-101-14

7

(866) 649-9550

March 29 & 30

Fort Worth, Texas

SCABB Mission It is the goal of the South Central

Association of Blood Banks to provide

opportunities for members to enhance their abilities to

deliver quality blood services.

7

Detailed Schedule

Hiding in Plain Sight

9:00 - 10:00 AM

Speaker: Mark D Scott, PhD

Senior Scientist

Canadian Blood Services - CBR

Presentation: Polymer-mediated Immunocamouflage of Cells

Description: Alloimmunization to RBC blood group antigens causes significant

clinical problems. Outside of serological matching, little can be done to prevent

or overcome this issue. The immunocamouflage of RBC by chemically grafted,

biologically inert, polymers may be a solution to this problem.

Objectives:

1. Problem of Blood Group Alloimmunization

2. Describe the concept of "immunocamouflage"

3. Use of Immunocamouflage to treat/prevent alloimmunization

PACE/CME Credits: 1 PACE/CME

151-102-14

www.scabb.org



8

Detailed Schedule

Star Wars, the Empire Strikes Back

10:15 - 11:45 AM

Speaker: Joann Moulds, PhD, MT(ASCP)SBB

Scientific Director

Grifols Immunohematology Center

Sue Johnson, MSTM, MT(ASCP)SBB

Director, Clinical Education

BloodCenter of Wisconsin

Presentation: Star Wars, The Empire Strikes Back

Description: Darth DNA is taking over the galaxy spreading genotyping every-

where but the Top Gun Serologists fight back with their most complex cases.

Who will win the battle of the blood groups? Only the audience knows as they

battle with their radio frequency participation devices.

Objectives:

1. Discover how others approach serological problems.

2. Utilize efficient and reliable processes for problem resolution integrating red

cell genotyping.

3. Learn the latest information on serological and molecular testing.

PACE/CME Credits: 1.5 PACE/ 1.5 CME

151-103-14

9

(866) 649-9550

March 29 & 30

Fort Worth, Texas

9

Detailed Schedule

AIMS INDUSTRY WORKSHOP: Presented by Grifols

Location: Continental Room, Hilton Fort Worth

12:00 – 1:00 PM

Speaker: Mark Yazer, MD

Presentation: Preventing Alloimmunization in the Chronically Transfused

Description: The presentation will identify individuals and associated red cell anti-

gens at risk of adverse transfusion reactions. Alloimmunization associated with

transfusions and pregnancy will be addressed as well as strategies such as extend-

ed typing, genotyping and registries in high risk populations.

Objectives:

1. Identify antigens at risk of causing alloimmunization.

2. Recall populations at risk for alloimmunization.

3. Explain the importance of phenotyping and antigen avoidance in transfusion

practices, and describe strategies which could reduce the risk in various patient

groups.

4. Describe strategies which could reduce the risk in various patient goups

Lunch will be offered by: Grifols

*Registration not required*

www.scabb.org



10

Detailed Schedule

Are We Doing It Right?

1:15 - 2:45 PM

Speaker: Margaret A. Keller, PhD

Director, National Molecular Laboratory

American Red Cross

Presentation: Discrepancies between Molecular and Serologic Testing for Red

Cell Antigens

Description: The American Red Cross has been using the BioArray Solutions HEA

BeadChip platform for predicting red cell antigens since 2008. Currently, the Red

Cross screens ~20,000 donors per year to meet the antigen-negative blood needs

of patients. When predicted phenotype and serologic phenotype are discordant, an

investigation is performed. Through these investigations, both known and novel

variants have been identified and limitations of the genotyping platform have been

demonstrated. The compilation of these findings will be presented and review of

these experiences should be useful to reference laboratory staff who perform anti-

gen confirmation of genotype-predicted red cell phenotypes.

Objectives:

1. To describe the basis of RBC genotyping

2. To review the RBC genotyping platform used by the American Red Cross, its

contents and limitations

3. To categorize the types of discrepancies seen between serologic phenotype

and phenotype predicted by genotyping and their resolution.

11

(866) 649-9550

March 29 & 30

Fort Worth, Texas

11

Detailed Schedule

VISIT OUR AIMS SPONSORS! Be sure to check out our 2014 AIMS sponsors before

sessions begin, during breaks and after AIMS sessions!

They will be located in the back of Texas B,C & D,

ready to showcase all they have to offer.

Are We Doing It Right? continued...

Speaker: Mary A Lieb MT(ASCP)SBB, CQA(ASQ)

Director, Quality Source

Blood Systems

Presentation: Competency Assessment: The Whys and How

Description: A renewed focus on establishing a process for determining staff com-

petency using all the 6 elements of evaluation was revisted by CMS in January of

2013. Since molecular testing for red cells has been determined reimbursable by

CMS in October of 2013, will competency requirements be applied to molecular

testing? This presentation will discuss the reasons for competency and how a

competency program can be designed to use every day activities and proficiency

testing to establish competency for molecular testing

Objectives:

1. List CLIA requirements for competency.

2. Discuss who needs to be evaluated and deemed competent to perform testing

3. Identify what daily elements can be incorporated into a competency assess-

ment program.

PACE/CME Credits: 1.5 PACE / 1.5 CME

151-104-14

www.scabb.org



12

Detailed Schedule

Case Studies

3:00 - 5:00 PM

Moderator: Katrina Billingsley, MT(ASCP) SBB

Speaker(s): Brian Jones, SBB(ASCP)CM

Clinical Laboratory Supervisor, Cellular Therapy Laboratory

Blood Systems Laboratories

Sandy Wortman, MT(ASCP)SBB

Director - Reference and Transfusion

Carter BloodCare

Virginia Reyes, M.Ed., MT(ASCP)SBBCM

IRL Technologist

Carter BloodCare

David Hanna, MT(ASCP)CM

Med Tech II


Description: Grab a chair and come sit at our "round tables" as we take a closer

look at a selection of complex immunohematology cases. Utilizing serology, geno-

typing and MMA technologies, these cases are sure to keep you on the edge of

your seat.

Objectives:

1. Analyze the serological results of complex cases

2. Discuss the application of methods used for resolution

3. Review the blood group system of the antibody pertinent to the case study

PACE/CME Credits: 2 PACE / 2 CME

151-105-14

13

(866) 649-9550

March 29 & 30

Fort Worth, Texas

13

Detailed Schedule

Sunday, March 30

Let’s Talk About Platelets

8:30 - 10:00 AM

Speaker: Stan Hance, MT(ASCP)

Platelet Services Coordinator

Carter BloodCare

Katrina Billingsley, MT(ASCP) SBB

Supervisor, Clinical Immunogenetics


Frank Nizzi, DO

VP of Clinical Services

Blood Systems, Inc.

Presentation: My Patient is Refractory, Where do I Start?

Description: Providing compatible platelets for patients with immune-mediated

refractoriness is a complex but commonly encountered clinical scenario. Join us

for a review of current literature and a discussion on how laboratory and transfu-

sion medicine professionals can best assist these challenging patients. Topics of

discussion will include laboratory methods available used to determine cause of

refractoriness as well as the review of a platelet genotyping program.

www.scabb.org



14

Detailed Schedule

Let’s Talk About Platelets continued...

Objectives:

1. Discuss methods available for investigating and treating the refractory patient

with platelet reacting antibodies.

2. Discuss platelet genotypes by evaluation of a donor screening program.

3. Review clinical strategies for managing the platelet refractory patient.

CONTINUING EDUCATION CREDITS (CEU’s)

South Central Association of Blood Banks is approved as a provider of contin-

uing education programs in the clinical laboratory sciences by the ASCLS

P.A.C.E. ® Program. Participants attending one session in each time block

will earn a maximum of 10 contact hours.

Accreditation

This activity has been planned and implemented in accordance with the

Essential Areas and policies of the Accreditation Council for Continuing

Medical Education through the joint sponsorship of Ochsner Clinic

Foundation and Advanced Immunohematology and Molecular Symposium.

The Ochsner Clinic Foundation is accredited by the ACCME to provide

continuing medical education for physicians.

Designation

The Ochsner Clinic Foundation designates this live activity for a maximum of

10.25 AMA PRA Category 1 Credits™. Physicians should claim only the

credit commensurate with the extent of their participation in the activity.

15

(866) 649-9550

March 29 & 30

Fort Worth, Texas

15

Detailed Schedule

Remembering the History

10:15 - 11:00 AM

Speaker: Tony S. Casina MT(ASCP)SBB

Marketing Manager

Ortho Clinical Diagnostics

Presentation: The Evolution of the Commercialization of Specialty Reagents in

Immunohematology

Description: This presentation covers the many contributions to unique reagent

development and made commercially available that John J. Moulds has made to

the Immunohematology industry. The prolific numbers of reagents and the sero-

logical techniques the reagents addressed made complex to make reagents and

technical applications readily available for all Immunohematologists to effectively

use.

Objectives:

1. Understand the history of development of specialty reagents used in

Immunohemtology

2. Provide an overview of how unique reagents were developed

3. Recognize the value and importance of these reagents to everyday transfusion

service testing and immunohematology problem solving

JOHN MOULDS MEMORIAL LECTURER

11:00 - 12:00 PM

Speaker: W. John Judd, FIBMS, MIBiol

Emeritus Professor

Department of Pathology, University of Michigan

www.scabb.org



16

Detailed Schedule

John Moulds Lecturer continued…

Presentation: Remembering the history - John Moulds Memorial Lecture

Description: This presentation will address the topics of lectins and polyagglutina-

tion, which are rarely addressed at scientific meetings or in transfusion medicine

journals.

Objectives:

1. Differentiate between polyagglutination and panagglutination

2. Prepare an anti-T lectin from peanuts

3. Determine the type of polyagglutination given the results from a lectin panel.

Endowed by: LifeShare Blood Centers & Quotient Biodiagnostics

PACE/CME Credits: 1.5 PACE/1.75 CME

John Moulds

John’s career as an immunohematology

reference lab specialist began with an interest

in high and low incidence blood group

antigens. He also had a unique ability to

recognize and adapt techniques for use by the

serologist in investigation of simple and complex problems. His leadership and

participation in various organizations showed his willingness to share his

knowledge. Some of these included Invitational Conference of Investigative

Immunohematologists (ICII), ASCP, AABB, ISBT, and SCABB. He formed the

Serum, Cell and Rare Fluid (SCARF) international exchange in 1972 and served as

its director for almost 40 yrs.

17

(866) 649-9550

March 29 & 30

Fort Worth, Texas

17

Detailed Schedule

INDUSTRY WORKSHOP: Presented by Healthcare ID

Location: Continental Room, Hilton Fort Worth 2:15 - 3:15PM

Speaker: Bart Block

Director, Management Information Systems

Gulf Coast Regional Blood Center

Presentation: Implementation of the Abbreviated Health History Questionnaire

(aDHQ)

Description: Gulf Coast Regional Blood Center discusses the implementation of the

aDHQ at their center. Topics of discussion includes the steps taken, along with

any obstacles, lessons learned, staff feedback, donor feedback, etc.

Objectives:

1. To provide other blood centers with an understanding of what it takes to suc-

cessfully implement the abbreviated healthy history questionnaire.

www.scabb.org



18

SCABB Annual Meeting

SCABB Opening Plenary: Award Lecturers

Location: Crystal Ballroom A

3:30 - 6:30PM

Technical/Scientific Award Lecturer

Speaker: Scott Jones, PhD

Vice President of Scientific Affairs

QualTex Laboratories

Presentation: The History, Present and Future of Blood Transfusion

Description: Nucleic Acid Testing (NAT) of whole blood and source plasma dona-

tions has been in place in the United States since 1999. Originally screening for

just HIV-1 and HCV RNA we now screen for a variety of viruses using NAT. The

assay your laboratory needs is not always commercially available so why not devel-

op NAT assays in order to meet the testing needs of your customers. Key factors

in developing NAT assays and performance of QualTex in-house developed as-

says will be discussed.

Objectives:

1. Understanding of the key factors in developing NAT assays.

2. Understanding of the performance characteristics of QualTex developed NAT

assays.

3. Understanding of possible future NAT assays.

19

(866) 649-9550

March 29 & 30

Fort Worth, Texas

19


Enhanced Networking!

SCABB is excited to offer AIMS attendees enhanced networking abilities through a

mobile app called, Bloodhound. Simply download the app, scan another

attendees badge and instantly capture their contact information!

SCABB Opening Plenary: Award Lecturers continued...

Administrative Award Lecturer

Speaker: Joann Moulds, PhD, MT(ASCP)SBB

Scientific Director, Immunohematology

Grifols Diagnostic

Presentation: Growing the Next Generation - Where Have All The Flowers

Gone?

Description: Being a good administrator means ensuring that properly trained per-

sonnel are available to perform the work. Are we accomplishing this goal or fail-

ing miserably? This lecture will be an insightful look at how and where our next

generation of leaders is coming from.

Objectives:

1. List the available types of training programs for laboratory personnel

2. Project future needs for technical and managerial personnel

3. Suggest a way that an administrator can help fill the gap

www.scabb.org



20


SCABB Opening Plenary: Award Lecturers continued...

Karen Williams Memorial Lecture

Speaker: Evan Bloch, MD, MS

Associate Clinical Investigator

Assistant Adjunct Professor

Blood Systems Research Institute

University of California San Francisco

Presentation: Advances of Blood Safety

Description: Overview of the past, present and anticipated future of blood banking.

Objectives:

1. Review the history of blood banking and how past lessons contributed to

contemporary blood banking

2. Describe both the seminal accomplishments as well as the setbacks in modern

blood banking and how these have informed decision making and policy.

3. To extend a description of advances in blood safety to the future: that which is

likely to occur vs. that which is not to be i.e. “the world of blood substitutes”

PACE/CME Credits: 2.5 PACE/CME

151-108-14

21

(866) 649-9550

March 29 & 30

Fort Worth, Texas

21

NOTES:

www.scabb.org



22

NOTES:

23

(866) 649-9550

March 29 & 30

Fort Worth, Texas

23

NOTES:

South Central Association of Blood Banks

2901 Richmond Road, Suite 130-176

Lexington, KY 40509

(866)649-6550

www.scabb.org

THANK YOU To Our Sponsors!

Documents

2014 Final Program - SCABB